Actavis New Zealand

As of 03-Aug-16, Actavis Generics was acquired by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. For more information, visit

Teva Acquires Actavis Generics


Now we have the global resource to bring the best possible generic options to New Zealand.

We have an industry leading global product portfolio of more than 750 molecules offered in more than 1,700 different combinations and dosage forms through our global operations, which includes all significant drug delivery technologies.